Stumpf H P, Hüfner M, Hermann H J, Kimmig B
Klin Wochenschr. 1984 May 2;62(9):417-22. doi: 10.1007/BF01742299.
The follow-up of 15 patients with differentiated cancer of the thyroid was analysed retrospectively. All patients had persistent or developed elevated thyroglobulin (Tg) plasma levels (greater than 10 ng/ml) after total thyroidectomy and 131 I therapy. There was no evidence of thyroid remnants or metastases in the 131 I whole body scan, bone scan, chest X-ray or clinical investigation. Nine of 15 patients developed local or distant metastases during a follow-up period of 3-39 months (mean = 18 months). Only one of seven recurrences tested were 131 I positive, Tg values of 9 from 12 patients showed no correlation to the Thyroid-stimulating hormone (TSH) level. It is concluded that: (1) this group of patients is at high risk of developing a recurrence (2) new methods have to be developed for the localization of 131 I negative but Tg positive metastases.
对15例分化型甲状腺癌患者的随访情况进行了回顾性分析。所有患者在全甲状腺切除及131碘治疗后,甲状腺球蛋白(Tg)血浆水平持续升高或出现升高(大于10 ng/ml)。131碘全身扫描、骨扫描、胸部X线检查或临床检查均未发现甲状腺残余或转移证据。15例患者中有9例在3 - 39个月(平均18个月)的随访期内出现局部或远处转移。7例复发患者中只有1例131碘检查呈阳性,12例患者中有9例的Tg值与促甲状腺激素(TSH)水平无关。得出以下结论:(1)该组患者复发风险高;(2)必须开发新方法来定位131碘阴性但Tg阳性的转移灶。